View Partner Button
Picture of researcher

Cancer Clinical Trials

Site: Genitourinary

The most recent listing of current clinical trials for genitourinary cancers — including prostate, bladder, testicular and kidney — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
 

Site: Genitourinary
(Includes Prostate, Bladder, Testicular and Kidney)

Protocol ID    Title

RTOG 0534    A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy

Keywords: Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy

In-House    Management of Intra-Fractional Prostate Motion During Radiation Therapy

Keywords: radiation therapy

RTOG 0621    Adjuvant 3DCRT/IMRT in Combination with Andgrogen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post- Prostatectomy: A Phase II Trial

Keywords: High Risk Prostate Cancer Patients Post- Prostatectomy

RTOG 0524    Phase I/II Trial of a Combination of Paclitaxel alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer

Keywords: after transurethral surgery for non-cystectomy patients with muscle invasive bladder cancer

In-House    Phase I/II Trial Examining Dose-Per-Fraction Escalation Using Intensity Modulated Radiation Therapy in the Treatment of Prostate Cancer

Keywords: prostate cancer

U of C 14954A    A Randomized, Phase II Study of GW786034 (Pazopanib) in Stage D0 Relapsed Androgen Sensitive Prostate Cancer Following Limited GnRH Agonist Therapy

Keywords: Stage D0 Relapsed Androgen Sensitive Prostate Cancer

A6181120    A Multicenter, Randomized, Double-Blind, Phase III Study of Sunitinib plus Prednisone v. Prednisone in Patients with Progressive Metatstatic Hormone-Refractory Prostate Cancer after Failure of a Docetaxel-Based Chemotherapy Regimen

Keywords: Patients with Progressive Metatstatic Hormone-Refractory Prostate Cancer

E2804    A Randomized Phase II Study of VEGF, RAF Kinase, and mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib and Temsirolimus in Advanced Renal Cell Carcinoma

Keywords: advanced renal cell canrcinoma

In-House    Safety of Biclutamide in chemoprevention of transitional cell carcinoma of the bladder treated with BCG

Keywords: transitional cell carcinoma of the bladder treated with BCG

In-House    Urinary HMGB1 in Subjects with Urologic Diseases

Keywords: urologic diseases

Industry 15    A Phase III, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 10 mg in Non-Metastatic Hormone-Resistant Prostate Cancer Patients

Keywords: non-metastatic hormone-resistant prostate cancer patients

Industry 14    A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic.

Keywords: Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic

Industry 33    A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 in Combination with Docetaxel in comparison with Docetaxel in Patients with Metastatic Hormone-Resistant Prostate Cancer

Keywords: patients with metastatic hormone-resistant prostate cancer

HIFU    Investigational Plan EDAP Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU) Indicated for Treatment of Low Risk, Localized Prostate Cancer

Keywords: localized prostate cancer

Industry    A Randomized Double-Blind Parallel Group Study Comparing Casodex 50mg plus Placebo to Casodex 50mg plus dutasteride 3.5mg Administered for 18 months to Men with Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA) Followed by a Two-Year Extension Phase AVO108943

Keywords: Men with Prostate Cancer Who Have Failed First-Line Androgen Deprivation Therapy (Assessed by Rising PSA)

In-House    MicroRNA Distribution along Human Nephrons Bank.

Keywords:

S0421    Phase III Study of Docetaxel and Atrasentan vs. Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer

Keywords: Advanced Hormone Refractory Prostate Cancer

RTOG 0873/ NCIC CTG PR.11    A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer (START)

Keywords: Favourable Risk Prostate Cancer

E3805    CHAARTED: ChemoHormonal Therapy v. Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer

Keywords: Extensive Disease in Prostate Cancer

U of C 15393B    A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Testosterone Replacement in Men with Non-Metastatic Castrate Resistant Prostate Cancer

Keywords: Non-Metastatic Castrate Resistant Prostate Cancer

In-House: Frailty & Mobility Disorder    Development of Frailty and Mobility Disorders in Older Prostate Cancer Patients on Androgen Deprivation Therapy

Keywords: Older Prostate Cancer Patients on Androgen Deprivation Therapy

EFC6668    Randomized Study of Larotaxel + Cisplatin  (LC) vs. Gemcitabine + Cisplatin (GC) in the First Line Treatment of Locally Advanced/ Metastatic Urothelial Tract or Bladder Cancer

Keywords: First Line Treatment of Locally Advanced/ Metastatic Urothelial Tract or Bladder Cancer

Univ. of Michigan 2005.145    Randomized Blinded Phase II Trial of Maintenance SU011248 vs. Placebo Post Chemotherapy for Patients with Advanced Urothelial Carcinoma

Keywords: Advanced Urothelial Carcinoma

 

 

Last Review Date: Nov. 18, 2009

Online Editor(s): Richard Petre

e-Newsletters

Monthly articles about the health topics of your choice!

Sign Up Today Sign Up Today

Log In to My Froedtert Log In to My Froedtert

Related Information
Quick Links
© 2009 Froedtert & The Medical College of Wisconsin
9200 West Wisconsin Avenue
Milwaukee, WI 53226